RVNC
Revance Therapeutics, Inc.
RVNC
RVNC
Delisted
RVNC was delisted on the 5th of February, 2025.
134 hedge funds and large institutions have $828M invested in Revance Therapeutics, Inc. in 2019 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 49 increasing their positions, 27 reducing their positions, and 14 closing their positions.
Holders
134
Holders Change
+25
Holders Change %
+22.94%
% of All Funds
2.65%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
39
Increased
49
Reduced
27
Closed
14
Calls
$1.65M
Puts
$2.08M
Net Calls
-$435K
Net Calls Change
-$228K
Top Buyers
| 1 |
1
JPMorgan Chase & Co
New York
|
$65.3M |
| 2 |
DM
2
Deerfield Management
New York
|
$14.6M |
| 3 |
3
Capital International Investors
Los Angeles,
California
|
$18.9M |
| 4 |
PA
4
Perceptive Advisors
New York
|
$13.3M |
| 5 |
PC
5
Polar Capital
London,
United Kingdom
|
$12.1M |
